Antithrombotic Therapy after Acute Coronary Syndromes

N Engl J Med. 2021 May 13;384(19):1873. doi: 10.1056/NEJMc2103789.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Anticoagulants / therapeutic use
  • Fibrinolytic Agents* / therapeutic use
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors